Abstract
Commiphora erythraea (Burseraceae) resin derives from the bark injury of the plant, a small tree native to the Arabian Peninsula. The resin is commonly known as myrrh and it is traditionally used to protect livestock from ticks and to treat diseases related to inflammation. The resin is constituted by a volatile and a non-volatile fraction. The volatile fraction is a source of furanosesquiterpenoids among which furanodienone showed to be the most promising pharmacological active compound. The composition and pharmacological activities of the extracts and the isolated compounds have been reviewed.
